Ethical consideration
The study was approved by the institutional review board of the university and study hospital (No. L2022SYSU-HL-004). The experts were fully informed of the purpose, significance, research contents, and methods of the study. Informed consent was obtained from all experts included in the study. All the participants in the pilot clinical trial voluntarily signed the informed consent, with the assurance of the confidentiality of personal information and the security of data. The participants were informed that there was no additional fee to participate in the study. They could withdraw from the study at any time.